18 May 2013
Keywords: roche, valcyte, works, up, days, trial, swiss
Article | 23 February 2009
Swiss drug major Roche met its primary in a Phase III study investigating the efficacy and safety prophylaxis with Valcyte
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
23 February 2009
17 May 2013
© 2013 thepharmaletter.com